Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 7OTHER 2NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Other 1Gastrointestinal 1Breast 1

Conditions

Thyroid Neoplasms 5Thyroid Cancer, Papillary 2Carcinoma, Non-Small-Cell Lung 2Thyroid Diseases 1Thyroid Carcinoma, Anaplastic 1Sexual Dysfunction, Physiological 1Neoplasms 1Gastrointestinal Neoplasms 1Eunuchism 1Erectile Dysfunction 1Carcinoma, Medullary 1Cachexia-Anorexia Syndrome 1Breast Neoplasms 1Advanced Thyroid Cancer Patients Who Received Target Therapy 1Adenocarcinoma, Follicular 1

Interventions

Carboplatin 330Pemetrexed 266Cisplatin 234Docetaxel 195Paclitaxel 182Radiotherapy 181Erlotinib Hydrochloride 153pembrolizumab 147Gemcitabine 147Bevacizumab 125Drug Therapy 121Radiosurgery 115Nivolumab 112osimertinib 92durvalumab 88Gefitinib 67atezolizumab 63Vinorelbine 63Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 54anlotinib 42Immunotherapy 42Taxes 39Blood Specimen Collection 39Ipilimumab 38130-nm albumin-bound paclitaxel 38Specimen Handling 36Immune Checkpoint Inhibitors 35Radiation 34Albumin-Bound Paclitaxel 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Non-Small-Cell Lung × selpercatinib × Clear all
NCT06532149 2024-08-09

EROS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
80 enrolled
OtherThoracic

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

NCT04591431 2023-10-03

ROME

Fondazione per la Medicina Personalizzata

Phase 2 Unknown
400 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡